Date Filed | Type | Description |
10/16/2012 |
8-K
| Quarterly results |
09/28/2012 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities |
09/19/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
09/14/2012 |
8-K
| Other Events |
09/12/2012 |
8-K
| Other Events |
08/31/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/30/2012 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
08/24/2012 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
08/22/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/21/2012 |
8-K
| Other Events |
08/14/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
08/14/2012 |
8-K
| Quarterly results |
07/03/2012 |
8-K
| Form 8-K - Current report |
06/21/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
05/25/2012 |
8-K
| Resignation/termination of a director |
05/15/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
05/15/2012 |
8-K
| Conference call transcript |
05/15/2012 |
8-K
| Quarterly results, Appointed a new director |
05/08/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
04/04/2012 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/26/2012 |
PRN
| OncoSec Announces $7.75 Million Public Offering |
03/16/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
03/14/2012 |
8-K
| Form 8-K - Current report |
03/13/2012 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements |
02/23/2012 |
8-K
| Form 8-K - Current report |
02/07/2012 |
PRN
| Spherix Announces Closing of Registered Direct Offering of $1.15 Million in Common Stock and Warrants |
02/02/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
01/19/2012 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
01/19/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
12/16/2011 |
S-3/A
| Form S-3 - Registration statement under Securities Act of 1933 [amend] |
12/09/2011 |
PRN
| Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants |
11/23/2011 |
PRN
| IceWEB, Inc. Completes a Private Placement of Convertible Notes for Principal Amount of $2,012,500 |
11/18/2011 |
8-K
| Form 8-K - Current report |
11/14/2011 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933 |
|